A detailed history of Jain Global LLC transactions in Merus N.V. stock. As of the latest transaction made, Jain Global LLC holds 10,127 shares of MRUS stock, worth $482,349. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,127
Holding current value
$482,349
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$41.45 - $54.5 $419,764 - $551,921
10,127 New
10,127 $426 Million

Others Institutions Holding MRUS

About Merus N.V.


  • Ticker MRUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,878,200
  • Market Cap $2.19B
  • Description
  • Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...
More about MRUS
Track This Portfolio

Track Jain Global LLC Portfolio

Follow Jain Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jain Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jain Global LLC with notifications on news.